Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To establish organ affiliation of liver microparticles using forensic cytological method based on hepatocytes' morphological characteristics and to determine their species belonging according to the human IgG using a quantitative enzyme-linked immunosorbent assay (ELISA).

Material And Methods: Previously dried microparticles (from 0.2×0.1 to 0.2×0.3 cm in size) of the liver taken from the corpses of 8 people without signs of liver disease were examined. The samples were investigated using forensic cytological and quantitative ELISA methods by the «total-IgG-ELISA-HEMA» test-kit.

Results: The possibility of determining organ affiliation of the liver microparticles based on hepatocytes' morphological characteristics stained with acrichine, acridine orange and azure-eosin has been demonstrated. It has been established that the high sensitivity and specificity of quantitative ELISA allow to determine the origin of liver microparticles from human. Optical density and IgG concentration in whole extracts were determined, optimal values of minimum and maximum calibration samples, namely 0.078±0.010-2.372±0.019 c.u., were obtained.

Conclusion: The obtained data can be used by experts of forensic biological units in establishing organ and species affiliation of liver microparticles found on trauma guns using forensic cytology and quantitative ELISA methods.

Download full-text PDF

Source
http://dx.doi.org/10.17116/sudmed20256804129DOI Listing

Publication Analysis

Top Keywords

liver microparticles
20
affiliation liver
12
quantitative elisa
12
microparticles forensic
8
forensic cytology
8
cytology quantitative
8
quantitative enzyme-linked
8
enzyme-linked immunosorbent
8
immunosorbent assay
8
organ affiliation
8

Similar Publications

Objective: To establish organ affiliation of liver microparticles using forensic cytological method based on hepatocytes' morphological characteristics and to determine their species belonging according to the human IgG using a quantitative enzyme-linked immunosorbent assay (ELISA).

Material And Methods: Previously dried microparticles (from 0.2×0.

View Article and Find Full Text PDF

Respiratory fistulas remain clinically challenging in endoscopic treatment due to the absence of convenient non-compressive sealing materials. Here, we developed an in situ self-fused powder adhesive (PP powder) to address this limitation. This material integrates the adaptive conformability of hydrogel microparticles with the pressure-resistant sealing capability of bulk hydrogels via water-triggered self-assembly.

View Article and Find Full Text PDF

Silk proteins, such as silk sericin (SS) and silk fibroin (SF), have been shown to exhibit excellent biocompatibility, biodegradability, and low immunogenicity as drug delivery carriers. SS possesses antioxidant and anticancer adjuvant properties, whereas SF provides mechanical strength and structural stability, marking them as optimal materials for drug delivery systems. In this study, 3 μm discoidal silk protein particles (DSPs) based on silk sericin/silk fibroin (SS/SF) composites were developed for the loading of docetaxel (DTX).

View Article and Find Full Text PDF

This study evaluated the efficacy and safety of intrapleural perfusion with methotrexate-loaded tumor cell-derived microparticles (MTX-TMPs) combined with systemic therapy (ST) in patients with malignant pleural effusion (MPE) secondary to lung or breast cancer. In this multicenter, randomized, open-label trial, 102 patients were assigned 1:1 to receive either MTX-TMPs intrapleural perfusion (50 mL daily for 4 days) plus ST (cohort 1) or interleukin-2 (IL-2) intrapleural perfusion (50 mL every 3 days for three sessions) plus ST (cohort 2). The objective response rate (ORR) and disease control rate (DCR) of pleural effusion were evaluated in 91 patients (50 in cohort 1, 41 in cohort 2).

View Article and Find Full Text PDF

Microfluidics-based polymers are transforming drug delivery systems for liver cancer treatment as they enable precise synthesis of nano- and microparticles suitable for targeted therapy. The manufacture of programmable nanoparticles and tunable sizes is made possible by microfluidic platforms, which are essential for improving the effectiveness of medication administration. A wide range of therapeutic chemicals, including hydrophobic medications like doxorubicin, can be encapsulated in these systems to target liver cancers while reducing systemic toxicity effectively.

View Article and Find Full Text PDF